RK Statistics
  • Home
  • About RK Statistics
  • Consultancy
  • Training
    • Training for Non Statisticians
    • Training for Statisticians
    • Online Courses
  • IDMCs/DSMBs
  • Knowledge Bank
  • News
  • Contact

Statistical Consultancy


Dr Kay acts as a consultant for numerous pharmaceutical companies, in relation to study design and the analysis of data, statistical methodology in general, and at a strategic level in support of their regulatory submissions. He regularly supports companies in their interactions with the EMA, FDA and PMDA.

He is experienced in the application of Adaptive Designs and methodologies for interim analyses for efficacy and futility, finding innovative solutions to multiplicity issues. Richard has also worked extensively in Biosimilars, in the use of propensity scoring in non-randomised studies and more recently he has become involved in developments in relation to Estimands and missing data.
​
Richard has worked on regulatory submissions in many areas including Parkinson’s Disease, Depression, Acute Lymphocytic Leukaemia, Prostate Cancer, Biosimilars in Psoriasis, Therapeutic treatments for Coronavirus, C. Diff. Infection, and in several orphan indications including Ataxia, Primary Haemophagocytic Lymphohistiocytosis (HLH) and Veno-occlusive Disease and Multi-Organ Failure
​Contacting RK Statistics
​Brook House,
Mesne Lane,
Bakewell DE45 1AL, UK
Registered in England & Wales No. 6934610
Telephone: +44 (0) 1629 810093
Mobile: +44 (0) 7917 322603
Email: richard.kay@rkstatistics.com

​RK Statistics © 2021 All rights reserved
Site powered by Wish Cloud Ltd
  • Home
  • About RK Statistics
  • Consultancy
  • Training
    • Training for Non Statisticians
    • Training for Statisticians
    • Online Courses
  • IDMCs/DSMBs
  • Knowledge Bank
  • News
  • Contact